[Skip to Navigation]
Sign In
Editor's Note
March 28, 2019

Scientific Integrity and Data Accuracy

Author Affiliations
  • 1Editor, JAMA Oncology
  • 2University of Washington and Fred Hutchinson Cancer Research Center, Seattle
  • 3Deputy Editor, JAMA Oncology
  • 4Division of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston
JAMA Oncol. 2019;5(5):745. doi:10.1001/jamaoncol.2019.0656

Scientific integrity seems to be a rare commodity these days. In this issue of JAMA Oncology, we have a retraction of an article1 due to an analysis error brought to our attention by the authors themselves. We commend Jesper Lagergren, MD, PhD, and colleagues for discovering this mistake after their research was published and immediately contacting the journal to ensure that corrected information in the analysis and outcome was rapidly made available to our readers. Ensuring that accurate data are accessible to others for the foundation of future studies is the basis of scientific publishing. The honesty of authors, such as Dr Lagergren and colleagues, serves as an excellent example of scientific integrity.

Back to top
Article Information

Published Online: March 28, 2019. doi:10.1001/jamaoncol.2019.0656

Corresponding Author: Mary L. (Nora) Disis, MD, University of Washington and Fred Hutchinson Cancer Research Center, 850 Republican St, Brotman 221, PO Box 358050, Seattle, WA 98195-8050 (ndisis@uw.edu).

Conflict of Interest Disclosures: None reported.

Maret-Ouda  J, Wahlin  K, Artama  M,  et al.  Risk of esophageal adenocarcinoma after antireflux surgery in patients with gastroesophageal reflux disease in the Nordic countries.  JAMA Oncol. 2018;4(11):1576-1582. doi:10.1001/jamaoncol.2018.3054PubMedGoogle ScholarCrossref